Market Overview The global companion diagnostics market is experiencing significant growth fueled by the accelerating adoption of precision medicine and targeted therapies across oncology and beyond. The global companion diagnostics market is projected to surpass USD 10 billion through 2030, driven by increasing demand for biomarker-driven treatment decisions, expanding regulatory...